Thu Jun 26 12:30:00 UTC 2025: **Summary:**

Spain’s economy has consistently outperformed the rest of Europe since the Covid-19 pandemic, driven by strong domestic demand fueled by tourism, immigration, and public spending, as well as a growing pharmaceutical sector. While economists expect Spain to continue outshining its peers in 2025, they also warn of potential challenges. The country faces infrastructure limitations, the impact of potential trade tensions (particularly from the US and Germany), and demographic aging. Despite these headwinds, Spain’s pharmaceutical sector shows promise, and tourism continues to thrive, with shifting patterns enabling more efficient use of infrastructure. However, the country must address high public debt, political uncertainty, and the need for investment to sustain its positive economic trajectory.

**News Article:**

**Spain’s Economy Leads Europe Post-Pandemic, But Challenges Loom**

**Madrid, Spain** – Spain’s economy continues to outpace the rest of Europe, driven by tourism, immigration, and a burgeoning pharmaceutical sector. Experts anticipate this trend will continue in 2025, following a strong first quarter, with a GDP growth of 0.6%.

“We already know that economic growth in the first quarter of 2025 was very strong. That’s a solid starting point,” says Miguel Cardoso, chief economist for Spain at BBVA Research.

However, the country faces potential headwinds. Infrastructure weaknesses, as highlighted by a recent power blackout, could impact growth. Concerns also arise from potential trade disruptions ignited by Washington, including tariffs. Furthermore, demographic aging is a looming challenge.

Despite these concerns, key sectors are thriving. Tourism continues to expand, with Spain closing in on France as a top destination. Shifts in tourism patterns, with more frequent, shorter trips, are enabling more efficient use of existing infrastructure.

Spain’s pharmaceutical industry is also emerging as a success story, attracting global giants like Novartis and Roche to establish research centers. Spain is already one of the world leaders in clinical research and surpassing Germany, with fast approval times and cost-effective resources.

Economists warn that high public debt, political uncertainty, and relatively low levels of investment could hinder Spain’s long-term growth. The IMF recommends strengthening the national fiscal framework and adopting employment-friendly measures to address potential pension shortfalls. However, the IMF praised the stability of Spain’s financial system and banks.

Spain’s post-Covid success story hinges on maintaining sound fiscal and regulatory policies to ensure continued economic momentum.

Read More